FDA Inspection 760451 — Natren Inc.

Natren Inc. — FEI 2024261

The FDA completed an inspection of Natren Inc. on December 22, 2011 in Thousand Oaks, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 22, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Thousand Oaks, CA (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
194321 CFR 211.180(e)(1)Review of representative number of batches
202621 CFR 211.192Quality control unit review of records
202721 CFR 211.192Investigations of discrepancies, failures
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved